Our activity is mainly based on comprehensive supply of research laboratories with appropriate equipment and reagents used in research processes.
In our activity, we are guided by the principle of stable cooperation with clients by offering a wide range of products necessary to work in any laboratory - from reagents, through measuring apparatus, to laboratory furniture.
Our clients are industrial laboratories, scientific laboratories, laboratories of municipal enterprises, state supervision institutions or medical laboratories.
Our product portfolio includes: control and measurement equipment, laboratory equipment, laboratory furniture, chemical reagents, reagents for pharmacy, glass and laboratory porcelain, laboratory products made of plastic and metal, filtration and microbiology, spectrophotometry, apparatus and accessories for trace analysis (GC, HPLC, AAS), devices for the collection of solid, liquid and gas samples, sterile products and medical diagnostics.
Thanks to our several years of presence on the chemical market in Poland, our offer guarantees the highest quality, reliable technical advice and professional delivery. Thanks to the extensive sales network, we guarantee continuity of supply and short delivery times.
46.90.Z - Non-specialized wholesale trade
20.13.Z - Manufacture of other inorganic basic chemicals
20.41.Z - Manufacture of soap and detergents, cleaning and polishing preparations
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
23.13.Z - Production of household glass
26.51.Z - Manufacture of measuring, controlling, and navigation instruments
26.70.Z - Manufacture of optical instruments, magnetic and optical information carriers, and photographic equipment
31.09.Z - Manufacture of furniture
47.19.Z - Retail trade
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 5,1 | 4,3 | 5,5 | 29,1 |
EBITDA | 5,5 | 5 | 6,4 | 28 |
Short time liabilities | 10,2 | 12,7 | 13,3 | 4,8 |
Equity capital | 13,9 | 14,5 | 17,3 | 19,4 |
Operating profit (EBIT) | 4,9 | 4,3 | 5,5 | 27,8 |
Assets | 28,8 | 30,5 | 35,6 | 16,7 |
Net profit (loss) | 4,3 | 3,3 | 4,5 | 34,8 |
Cash | 9,2 | 7,1 | 9,3 | 29,5 |
Liabilities and provisions for liabilities | 14,9 | 16 | 18,3 | 14,2 |
Net income from sale | 74,1 | 85,5 | 98,9 | 15,8 |
Working assets | 25,6 | 27 | 30,9 | 14,7 |
Depreciation | 0,6 | 0,7 | 0,9 | 29,2 |
% | % | % | p.p. | |
Profitability of capital | 31,1 | 23 | 25,9 | 2,9 |
Equity capital to total assets | 48,2 | 47,5 | 48,6 | 1,1 |
Gross profit margin | 6,8 | 5 | 5,6 | 0,6 |
EBITDA Margin | 7,4 | 5,8 | 6,5 | 0,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 50 | 54 | 49 | -5 |
Current financial liquidity indicator | 1.7770382165908813 | 1.7080507278442383 | 1.72465181350708 | 0 |
Net dept to EBITDA | -1.4598102569580078 | -1.2978156805038452 | -1.3830121755599976 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane